Novel ibuprofen prodrug: A possible promising agent for the management of complications of Alzheimer’s disease

Background: Alzheimer’s disease (AD) is a severe, varied, and complex brain condition that gradually impairs memory and cognitive function. Epidemiological studies have shown that patients who have a history of long-term NSAID use have a decreased risk of developing AD. The objective of this study i...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Anjali Nayak, Rashu Raju, Paramita Das, Kuntal Das, A. Suvitha, Biswa Ranjan Meher, Saad Alobid, Ali Ibrahim Almoteer, Moneer E. Almadani, Ahmed Alshehri, Adel Alghamdi, Fuzail Ahmad, Syed Imam Rabbani, Syed Mohammed Basheeruddin Asdaq, Naira Nayeem
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Springer 2024-01-01
Edice:	Saudi Pharmaceutical Journal
Témata:	Alzheimer's disease Ibuprofen Prodrug Novel conjugate Drug effect Animals
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S1319016423003833
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!